Deepak Srivastava - 29 Jul 2021 Form 3 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Role
Director
Signature
/s/ Leone Patterson Attorney-in-Fact for Deepak Srivastava
Issuer symbol
TNYA
Transactions as of
29 Jul 2021
Net transactions value
$0
Form type
3
Filing time
29 Jul 2021, 19:52:36 UTC
Next filing
13 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TNYA Common Stock 191,666 29 Jul 2021 Direct
holding TNYA Common Stock 141,666 29 Jul 2021 See Footnotes F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TNYA Stock Option (Right to Buy) 29 Jul 2021 Common Stock 37,500 $2.70 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held directly by The J. David Gladstone Institutes for which the Reporting Person serves as President. The Reporting Person may be deemed to have voting and investment control over the shares. The Reporting Person disclaims beneficial ownership of these shares. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of any of the shares held by The J. David Gladstone Institutes for Section 16 or any other purpose.
F2 1/48th of the shares subject to the option granted on December 6, 2019 became vested and exercisable as of November 6, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter, provided that the Reporting Person remains a service provider to the issuer on each such vest date.

Remarks:

Date set forth above represents the effective date of the Issuer's initial public offering